Patents by Inventor Michael Ruane
Michael Ruane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260327086Abstract: A process for recovering syngenite from a brine having a higher magnesium (Mg) concentration (w/v) than potassium (K) concentration (w/v) is disclosed. The process includes the steps of a) concentrating said brine to obtain a first concentrated liquor having a K concentration approaching saturation, mixing with K depleted liquor from the syngenite precipitation reaction and allowing the combined liquor to further concentrate and separate into crystallised solids and a Mg-rich supernatant liquor. The Mg-rich supernatant liquor is then decanted and the crystallised solids are redissolved in water to obtain a second concentrated liquor comprising greater than 40 g/L K and a relative Mg to K concentration (w/v) of less than or equal to 1:1. The second concentrated liquor is then reacted with a less than stoichiometric amount of gypsum at less than 40° C. to produce syngenite and a potassium-depleted solution. The syngenite is separated according to conventional techniques.Type: ApplicationFiled: August 9, 2023Publication date: October 22, 2026Applicant: Reward Minerals LimitedInventors: Michael Ruane, Warren Hinchliffe
-
Patent number: 8729134Abstract: Compounds of formula (I): wherein R1 and R4 are OR7, R2 and R3 are H or OR7, with the proviso that when R2 is OR7 then R3 is H, and when R3 is OR7 then R2 is H; R5 and R6 are independently H, OH, or OR7 with the proviso that when R5 is OH, R6 is not OH; R7 is alkyl, aryl or arylalkyl; the drawing “” represents either a single or a double bond; or pharmaceutically acceptable salt(s) or prodrug(s) thereof. These compounds are useful of treatment, prophylaxis, amelioration, or defense against and/or prevention of hormonal dependent conditions, cancer, and diseases and conditions associated with oxidant stress.Type: GrantFiled: November 13, 2009Date of Patent: May 20, 2014Assignee: Heartlink LimitedInventors: Michael Ruane, Tracey-Ann Dickens
-
Publication number: 20110263721Abstract: Compounds of formula (I): wherein R1 and R4 are OR7, R2 and R3 are H or OR7, with the proviso that when R2 is OR7 then R3 is H, and when R3 is OR7 then R2 is H; R5 and R6 are independently H, OH, or OR7 with the proviso that when R5 is OH, R6 is not OH; R7 is alkyl, aryl or arylalkyl; the drawing “” represents either a single or a double bond; or pharmaceutically acceptable salt(s) or prodrug(s) thereof. These compounds are useful of treatment, prophylaxis, amelioration, or defense against and/or prevention of hormonal dependent conditions, cancer, and diseases and conditions associated with oxidant stress.Type: ApplicationFiled: November 13, 2009Publication date: October 27, 2011Applicant: HEARTLINK LIMITEDInventors: Michael Ruane, Tracey-Anne Dickens
-
Patent number: 7348152Abstract: An isolated RBP with at least one of the following characteristics: a) a molecular weight of approximately 65-70 kDa and more preferably 66-69 kDa; b) a pI of greater than 10 or less than 3; c) a dissociation constant of approximately 1.5×10?6 when bound to the rhamnose moiety of solamargine; d) adapted to bind to a rhamnose affinity column prepared according to example 1 and under the conditions set out therein; e) adapted to be eluted from the column in example 1 with a 100 mM rhamnose solution; f) insoluble in aqueous solution; and g) soluble in highly denaturing buffers containing greater that approximately 2% surfactant.Type: GrantFiled: March 3, 2005Date of Patent: March 25, 2008Assignee: Solbec Pharmaceutical LimitedInventors: Richard J. Lipscombe, Stephen John Carthr, Michael Ruane
-
Publication number: 20060182659Abstract: An assay system having a channel bounded by first and second reflective surfaces adapted to accommodate a fluid material therebetween and defining a plurality of regions in an array between those surfaces with each region defining a resonant cavity and adapted to receive a capturing material on a surface thereof whereby a source of radiation illuminates each region to provide a standing wave of radiation of within the cavity indicative of binding of said capturing agent to material under investigation, a binding thereof being detected in response to radiation from each cavity indicative of a change in the standing wave pattern.Type: ApplicationFiled: March 19, 2004Publication date: August 17, 2006Inventors: M Unlu, David Bergstein, Michael Ruane, Bennett Goldberg
-
Patent number: 6930171Abstract: An isolated RBP with at least one of the following characteristics: a) a molecular weight of approximately 65-70 kDa and more preferably 66-69 kDa; b) a pl of greater than 10 or less than 3; c) a dissociation constant of approximately 1.5×10?6 when bound to the rhamnose moiety of solamargine; d) adapted to bind to a rhamnose affinity column prepared according to example 1 and under the conditions set out therein; e) adapted to be eluted from the column in example 1 with a 100 mM rhamnose solution; f) insoluble in aqueous solution; and g) soluble in highly denaturing buffers containing greater that approximately 2% surfactant.Type: GrantFiled: February 7, 2003Date of Patent: August 16, 2005Assignee: Solbec Pharmaceuticals LimitedInventors: Richard J. Lipscombe, Stephen John Carter, Michael Ruane
-
Publication number: 20050170421Abstract: An isolated RBP with at least one of the following characteristics: a) a molecular weight of approximately 65-70 kDa and more preferably 66-69 kDa; b) a pI of greater than 10 or less than 3; c) a dissociation constant of approximately 1.5×10?6 when bound to the rhamnose moiety of solamargine; d) adapted to bind to a rhamnose affinity column prepared according to example 1 and under the conditions set out therein; e) adapted to be eluted from the column in example 1 with a 100 mM rhamnose solution; f) insoluble in aqueous solution; and g) soluble in highly denaturing buffers containing greater that approximately 2% surfactant.Type: ApplicationFiled: March 3, 2005Publication date: August 4, 2005Applicant: Solbec Pharmaceuticals LimitedInventors: Richard Lipscombe, Stephen Carter, Michael Ruane
-
Publication number: 20040030104Abstract: An isolated RBP with at least one of the following characteristics:Type: ApplicationFiled: February 7, 2003Publication date: February 12, 2004Applicant: SOLBEC PHARMACEUTICALS LIMITEDInventors: Richard J. Lipscombe, Stephen John Carter, Michael Ruane
-
Patent number: 5108185Abstract: An apparatus for measuring the reflectivity of magnetooptic materials where the complex reflection coefficients of absorbing anisotropic media are determined. Amorphous rare-earth transition metal alloys exhibiting polar Kerr effect are analyzed for use as storage media in erasable optical storage systems.Type: GrantFiled: June 12, 1989Date of Patent: April 28, 1992Assignee: Boston UniversityInventors: Masud Mansuripur, Michael Ruane, Robert Rosenvold
-
Patent number: 4838695Abstract: An apparatus for measuring the reflectivity of magnetooptic materials where the complex reflection coefficients of absorbing anisotropic media are determined. Amorphous rare-earth transition metal alloys exhibiting polar Kerr effect are analyzed for use as storage media in erasable optical storage systems.Type: GrantFiled: June 12, 1987Date of Patent: June 13, 1989Assignee: Boston UniversityInventors: Masud Mansuripur, Michael Ruane, Robert Rosenvold